Full Press Release Details
OFFICIALLY AVAILABLE!!!
are excited to announce the official launch of #VitaGraft Kidney!
only available through Oncocyte's Early Access Program, VitaGraft Kidney is now broadly available to transplant professionals upon
Kidney is a blood-based test that measures donor-derived cell-free DNA (#dd-cfDNA) concentrations post-kidney #transplantation,
serving as an indicator for potential organ damage and rejection.
check out our newly designed VitaGraft Kidney web page!
#OCX #Innovation #WhereTomorrowLives $OCX
are excited to announce the #OfficialLaunch of #VitaGraft Kidney! Previously only available through Oncocyte's Early
Access Program, VitaGraft Kidney is now broadly available upon request.
#OCX #Innovation #WhereTomorrowLives